MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status.
MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker.
We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for guiding clinical decision-making.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Paris, Fr
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.msinsight.tech
- Keywords
- Microsatellite Instability, Next-Generation Sequencing, Diagnostic Test, Bioinformatics, Oncology, Precision Medicine, Hereditary Cancer, Defective Mismatch Repair.
- HQ
- Paris
Msinsight Questions
Msinsight's website is http://www.msinsight.tech
Msinsight's LinkedIn profile is https://fr.linkedin.com/company/msinsight
Msinsight has
12 employees.
View email and phone details for 12
employees at Msinsight.
Msinsight's industry is
Medical Equipment Manufacturing
Msinsight's top competitors are
Opusmajor,
Sezame,
Cherico®,
Deskoin,
Beyond Green 🌱,
Ostrea,
Fizimed,
Valused,
The Babel Community,
Drugoptimal.
Msinsight's categories are Medical Equipment Manufacturing
Msinsight's founding year is 2022
